pyrroles has been researched along with Glomerulonephritis, Lupus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolaños, N; Cruzado, JM; de Ramon, L; Draibe Bordignon, J; Goma, M; Grinyó, JM; Merino, A; Ripoll, È; Torras, J | 1 |
| Cook, HT; Ehrenstein, MR; Jury, EC; Lawman, S; Mauri, C | 1 |
| Ishibashi, A; Kobayashi, S; Nagai, M; Seino, K; Shikata, K; Tokuhara, N; Yamauchi, T | 1 |
| Cairns, T; Cook, HT; Elliot, V | 1 |
4 other study(ies) available for pyrroles and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
JAK3-STAT pathway blocking benefits in experimental lupus nephritis.
Topics: Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Gene Expression Profiling; Janus Kinase 3; Lupus Nephritis; Mice; Mice, Inbred NZB; Piperidines; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; STAT Transcription Factors; Transcriptome | 2016 |
Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice.
Topics: Animals; Atorvastatin; B-Lymphocyte Subsets; Cell Proliferation; Cholesterol; Crosses, Genetic; Down-Regulation; Female; Growth Inhibitors; Heptanoic Acids; Histocompatibility Antigens Class II; Hypolipidemic Agents; Immunosuppressive Agents; Kidney; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred NZB; Pyrroles; Spleen; T-Lymphocytes; Time Factors | 2004 |
Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice.
Topics: Animals; Antibodies, Antinuclear; Benzoates; Benzofurans; Blood Urea Nitrogen; Female; Immunoglobulin G; Immunoglobulin M; Interleukin-12; Kidney; Lupus Nephritis; Mice; Mice, Inbred NZB; Proteinuria; Pyrroles; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Survival Rate | 2005 |
Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Biopsy, Needle; Disease Progression; Follow-Up Studies; Hematuria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Organelles; Plasma Exchange; Pyrroles; Sclerosis; Severity of Illness Index; Software Design | 2006 |